Table 2.
Control | Hexanoic | Infected | Hexanoic infected | |
---|---|---|---|---|
Camphor | N. D. | N. D. | 56,3 ± 2,6 b | 103,6 ± 16,3a |
3-Carene | 52,6 ± 7,1b | 40,2 ± 6,8b | N. D. | 218,4 ± 11,1a |
Alfa pinene | 11172,1 ± 3241,2b | 4057,2 ± 516,3b | 7949 ± 1398,6b | 25355 ± 3978,6a |
Terpineol | 572,8 ± 115,2c | 1619,3 ± 371,8bc | 2198,2 ± 292,9b | 4888,6 ± 599,1a |
1-Hexanol | 104,4 ± 16,5b | 102,5 ± 14,2b | 214,4 ± 10,2b | 784,6 ± 122,9a |
Gamma terpinene | 901,9 ± 126,2b | 539,8 ± 87,9c | 386,1 ± 100,4c | 1291,6 ± 157,1a |
Z-3-Hexen-1-OL | N. D. | 326,3 ± 40,2a | N. D. | 385 ± 66,8a |
R-Limonene | 5844,4 ± 2278,1ab | 1917,7 ± 345,9b | 2978,3 ± 421,8b | 14197,5 ± 6591,1a |
2-Carene | 153432,6 ± 19994,6b | 102867,6 ± 35641,6b | 190481,1 ± 22999,1b | 666924,6 ± 142808,6a |
E-2-Heptenal | 1128,8 ± 88,8b | 2681,4 ± 390,8a | 296,1 ± 33c | 937,2 ± 166b |
6-Methyl-5-Hepten-2-OL | 306,3 ± 79,4b | 321,9 ± 131,2b | 377,3 ± 83,6b | 951,9 ± 183,1a |
Beta-Ionone | N. D. | N. D. | 105,2 ± 9,8a | 119,7 ± 10,7a |
Linalool | 49670,4 ± 15698,5c | 31500,3 ± 5307,8c | 175073,8 ± 20453b | 379571,7 ± 72799,9a |
6-Methyl-5-Hepten-2-one | N. D. | N. D. | 151,8 ± 22,8b | 255,4 ± 36,5a |
Ethyl salicylate | N. D. | N. D. | 163,6 ± 75,2a | 54,8 ± 41,9b |
1-Octanol | 6064,6 ± 920,5c | 5977,7 ± 602,3c | 20544,4 ± 1810,3b | 43556,5 ± 2545,7a |
Trans,Trans-2,4-Decadienal | N. D. | N. D. | 341 ± 218,2a | 115,8 ± 40,5b |
The data show the average of three independent experiments expressed in pmol/g Fresh weight ± SE. Different letters on the same row indicate significant differences for the compound between treatments. (P < 0.05). N.D. means compound not detected.